Mr. Taha's Success Story

Mr. T.Z., 34 years old — with a history of blood triglycerides of 700 and blood sugar of 400, high blood pressure, a prior diagnosis of bipolar disorder, and a family history of hypertension, blood lipids, cholesterol, and type 2 diabetes — joined Ketonia's medical commission on Tir 2, 1401 (June 23, 2022). His case history was as follows:
- Their current home blood sugar readings are 100 to 120.
- They visited their psychiatrist once every three months; Shahrivar of last year (August–September) was the date of the last visit.
- They have experienced episodes of overspending, talkativeness, and heightened libido. They have taken lithium for bipolar disorder since 1397 (2018–2019). When they started lithium their appetite increased, but their mood is now stabilized.
- They experience excessive drinking and frequent urination, and most of the time they nibble between meals.
- Recently they have been exercising once a week.
- They followed a raw vegan diet for six months but stopped it due to severe hair loss.
- They eat a normal-to-larger amount compared with the people around them.
- The patient's medications at the start of treatment:
- Valsartan 80 — morning and evening
- Bisoprolol 5 — one tablet in the morning
- Gliclazide 60 — morning and evening
- Glorenta 1000/12.5 — morning and evening
- Fenofibrate 200 — one tablet in the morning after breakfast
- Lithium carbonate 300 — three times a day
- Buspirone 5 — morning and evening
- Aripiprazole 5 — one tablet at night
- At the time of the commission, the patient's weight was recorded as 130 kg, height 185 cm, BMI 38, waist circumference 120 cm, and hip circumference 135 cm.
- In the patient's blood test of 16 Mordad 1400 (August 7, 2021): fasting glucose 120, two-hour glucose 222, and HbA1c 7.6, total cholesterol 211, and cholesterol HDL: 42; LDL cholesterol: 98; triglycerides: 344; AST: 30; and ALT: 90 were recorded.
- In the patient's blood test of 30 Tir 1401 (July 21, 2022): fasting glucose 108, HbA1c 6.38, total cholesterol 241, cholesterol HDL: 34; LDL cholesterol: 164; triglycerides: 344; AST: 54; ALT: 107; and CRP: 0.28 was recorded. Liver ultrasound interpretation also diagnosed grade 3 fatty liver.
With the explanations given in Ketonia's medical commission, the patient was very eager to join the Ketonia program. The Ketonia team therefore started its lifestyle-correction education and programs (nutrition, sleep, exercise, mental health, and medical care) for the patient right away.
The treatment goals set for the patient were as follows:
- Diabetes reversal
- Improved blood pressure
- Weight loss
- Improved fatty liver and metabolic syndrome
After about two weeks, following the Ketonia team's lifestyle education and the patient's good cooperation — considering the average fasting and two-hour glucose readings and the patient's healthy weight loss — Ketonia's medical commission decided to discontinue gliclazide.
- After about six months of progress and the Ketonia team's lifestyle education, the patient's average fasting glucose was 90, weight 118 kg (a 12 kg loss), waist 115 cm (a 5 cm loss), and hip 116 cm (a 19 cm loss), and the patient's average blood pressure was recorded as 120/80 — all indicating significant changes in the patient's laboratory and anthropometric markers. Based on these results and the medical commission's judgment, the patient currently takes the following medications. (Ketonia's commission never interfered with the patient's psychiatric medications.)
- The patient's current medications:
- Atorvastatin 20 — two tablets
- Lithium carbonate 300 — morning and evening
- Buspirone 5 — morning and evening
- Aripiprazole 5— one tablet at night
In the survey, the patient said that their previous diets came with no education, so they struggled to follow them and didn't know what rules to observe. Over these six months, with the help of Ketonia's diet and education, they no longer have that problem and their blood sugar is under control. Overall they are satisfied with the diet and the education; in addition, their mental state is good, their appetite and nibbling are under control, and their former hunger pangs are gone. They are currently trying to maintain their regular physical activity. Moreover, with the help of much of the education, they have also improved their mood compared with the past.
The patient is now following the Ketonia program and has been able, with the Ketonia team's support, to achieve a 12 kg weight loss and, with improved laboratory and anthropometric markers, after roughly six months, to bring their blood sugar and blood pressure under control through lifestyle and nutrition correction, staying safe from many of the complications of high blood sugar.

